TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,806,000 | -42.1% | 365,205 | +2.8% | 0.00% | -40.0% |
| Q4 2021 | $16,943,000 | -9.5% | 355,193 | +26.1% | 0.01% | 0.0% |
| Q3 2021 | $18,715,000 | -16.0% | 281,724 | -1.3% | 0.01% | -16.7% |
| Q2 2021 | $22,267,000 | +27.5% | 285,401 | +54.6% | 0.01% | +20.0% |
| Q1 2021 | $17,467,000 | -24.1% | 184,659 | -2.3% | 0.01% | -28.6% |
| Q4 2020 | $23,023,000 | +116.6% | 188,948 | +55.3% | 0.01% | +75.0% |
| Q3 2020 | $10,628,000 | – | 121,663 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |